Otofarma S.p.A. Logo

Otofarma S.p.A.

Provides tailored hearing solutions and remote diagnostics through a partner pharmacy network.

OTO | Euronext Growth

Overview

Corporate Details

ISIN(s):
IT0005663361
LEI:
815600FED560ACA5D783
Country:
Italy
Address:
N/A
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Otofarma S.p.A. is an Italian company that specializes in the design, manufacture, and marketing of custom hearing aids and related accessories. The company provides personalized otoacoustic medical devices, including in-the-ear (Endoauricular) and behind-the-ear (Retroauricular) models, to address hearing loss. A key part of its service offering is Teleaudiology, a telemedicine platform that facilitates remote otoscopic and audiometric examinations through a network of partner pharmacies. This allows specialists to prescribe and create precisely tailored hearing solutions for patients based on detailed diagnostic data. The company emphasizes its focus on comfort, discretion, and delivering a natural sound experience for its users.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-15 08:00
Regulatory News Service
OTOFARMA: NUOVO STABILIMENTO A MILANO PER RAFFORZARE LA CAPACITÀ PRODUTTIVA
Italian 302.4 KB
2025-10-15 08:00
Regulatory News Service
OTOFARMA: NEW PLANT IN MILAN TO BOOST PRODUCTION CAPACITY
English 316.5 KB
2025-10-01 09:18
Earnings Release
OTOFARMA: BOARD OF DIRECTORS APPROVES HALF-YEAR REPORT AND PRO FORMA CONSOLIDAT…
English 496.1 KB
2025-10-01 08:34
Earnings Release
OTOFARMA: CDA APPROVA LA RELAZIONE SEMESTRALE E I PROSPETTI CONSOLIDATI PRO-FOR…
Italian 548.2 KB
2025-09-08 17:49
Share Issue/Capital Change
OTOFARMA: announcement of change in share capital following full exercise of gr…
English 353.3 KB
2025-09-08 17:47
Share Issue/Capital Change
OTOFARMA: comunicazione di avvenuta variazione del capitale sociale a seguito d…
Italian 355.3 KB
2025-09-05 18:03
Director's Dealing
Internal Dealing
Italian 88.5 KB
2025-09-02 18:17
Share Issue/Capital Change
OTOFARMA: full exercise of the Greenshoe Option
English 320.7 KB
2025-09-02 18:14
Share Issue/Capital Change
OTOFARMA: esercizio integrale dell’opzione greenshoe
Italian 347.4 KB

Automate Your Workflow. Get a real-time feed of all Otofarma S.p.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Otofarma S.p.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Otofarma S.p.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

MYOMO, INC. Logo
Robotic arm braces using muscle signals to restore movement for people with upper-limb paralysis.
United States of America
MYO
NAKANISHI INC. Logo
Specialist in high-speed rotation tech for dental, surgical, and industrial precision tools.
Japan
7716
NanoenTek,Inc. Logo
Develops lab-on-a-chip diagnostic devices and lab equipment for research and clinical markets.
South Korea
039860
NanoVibronix, Inc. Logo
Develops portable ultrasound devices for non-invasive pain relief & infection prevention.
United States of America
NAOV
NeoDynamics AB Logo
Med-tech firm that developed a micropulse biopsy system for precise cancer diagnosis.
Sweden
NEOD
NEOFECT Co.,Ltd Logo
Smart, gamified rehab solutions for neurological and musculoskeletal recovery.
South Korea
290660
Neola Medical AB Logo
Develops a medical device for continuous, non-invasive lung monitoring of preterm infants.
Sweden
NEOLA
NEPHROS INC Logo
Develops high-performance water filters for pathogen control in medical & commercial markets.
United States of America
NEPH
Neuraxis, INC Logo
Develops FDA-cleared, drug-free neuromodulation devices for gut-brain disorders.
United States of America
NRXS

Talk to a Data Expert

Have a question? We'll get back to you promptly.